United Kingdom· GB-APID-4506911000001107
Modrenal 60mg capsules
A trilostane product containing trilostane, registered in United Kingdom by Genzyme Therapeutics Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Trilostane
- Manufacturer
- Genzyme Therapeutics Ltd
- Country
- United Kingdom (GB)
- ATC code
- H02CA01
- ATC class
- Trilostane
- Defined daily dose
- 0.36 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5030045000012
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trilostane in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bfd1e74d-d254-4e67-93c7-53b9655f1063 GET /v1/drugs/bfd1e74d-d254-4e67-93c7-53b9655f1063?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4506911000001107",
"desc": "Modrenal 60mg capsules (Genzyme Therapeutics Ltd)",
"form": "Oral capsule",
"vpid": "42090911000001103",
"source": "dmd",
"vtm_id": "777854004",
"strength": "60 mg",
"substance": "Trilostane",
"ingredient": "Trilostane",
"supplier_code": "2963301000001100"
}See everything about trilostane.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.